{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:01Z","timestamp":1786119361969,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,27]]},"DOI":"10.1097\/tp.0b013e3181bb43ec","type":"journal-article","created":{"date-parts":[[2009,11,22]],"date-time":"2009-11-22T03:15:55Z","timestamp":1258859755000},"page":"1194-1202","source":"Crossref","is-referenced-by-count":81,"title":["Everolimus With Very Low-Exposure Cyclosporine A in De Novo Kidney Transplantation: A Multicenter, Randomized, Controlled Trial"],"prefix":"10.1097","volume":"88","author":[{"given":"Maurizio","family":"Salvadori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Piera","family":"Scolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Dal Canton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tisone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Albertazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Gubbiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianbenedetto","family":"Piredda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghil","family":"Busnach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Sparacino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Goepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Berloco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Montanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Veroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bartezaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Corbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210211","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1034\/j.1600-6143.2003.00107.x","article-title":"Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation.","volume":"3","author":"Kovarik","year":"2003","journal-title":"Am J Transplant"},{"key":"R2-8-20210211","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1600-6143.2005.01063.x","article-title":"Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients.","volume":"5","author":"V\u0131tko","year":"2005","journal-title":"Am J Transplant"},{"key":"R3-8-20210211","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000164352.65613.24","article-title":"Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: A 3-year randomized, multicenter, phase III study.","volume":"80","author":"Lorber","year":"2005","journal-title":"Transplantation"},{"key":"R4-8-20210211","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/01.TP.0000140486.97461.49","article-title":"Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: A three-year phase II, randomized, multicenter, open-label study.","volume":"78","author":"Nashan","year":"2004","journal-title":"Transplantation"},{"key":"R5-8-20210211","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1432-2277.2006.00414.x","article-title":"12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients.","volume":"20","author":"Tedesco-Silva","year":"2007","journal-title":"Transpl Int"},{"key":"R6-8-20210211","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R7-8-20210211","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R8-8-20210211","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":"Predicting glomerular filtration rate after kidney transplantation.","volume":"59","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"key":"R9-8-20210211","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2307\/2530223","article-title":"Survival analysis of drug combinations using a hazard model with time-dependent covariates.","volume":"36","author":"Stablein","year":"1980","journal-title":"Biometrics"},{"key":"R10-8-20210211","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1037\/0022-006X.62.3.569","article-title":"Methods for the analysis of binary outcome results in the presence of missing data.","volume":"62","author":"Delucchi","year":"1994","journal-title":"J Consult Clin Psychol"},{"key":"R11-8-20210211","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-6143.2005.01177.x","article-title":"Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus.","volume":"6","author":"Larson","year":"2006","journal-title":"Am J Transplant"},{"key":"R12-8-20210211","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.tp.0000258586.52777.4c","article-title":"Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.","volume":"83","author":"Flechner","year":"2007","journal-title":"Transplantation"},{"key":"R13-8-20210211","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":"Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil, and a 6-month course of steroids.","volume":"7","author":"Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"R14-8-20210211","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-6143.2006.01645.x","article-title":"Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study.","volume":"7","author":"Ekberg","year":"2007","journal-title":"Am J Transplant"},{"key":"R15-8-20210211","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ndt\/15.9.1307","article-title":"Calcineurin-inhibitors in renal transplantation. Too precious to be abandoned.","volume":"15","author":"Ponticelli","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R16-8-20210211","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-6143.2006.01233.x","article-title":"Are we ready to give up on calcineurin inhibitors?","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"R17-8-20210211","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","article-title":"SDZ RAD, a new rapamycin derivative: Synergism with cyclosporine.","volume":"64","author":"Schuurman","year":"1997","journal-title":"Transplantation"},{"key":"R18-8-20210211","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/ndt\/14.10.2297","article-title":"Renal allograft thrombosis: Can thrombophilia explain the inexplicable.","volume":"14","author":"Irish","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R19-8-20210211","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R20-8-20210211","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1600-6143.2004.00462.x","article-title":"Association of center volume with outcome after liver and kidney transplantation.","volume":"4","author":"Axelrod","year":"2004","journal-title":"Am J Transplant"},{"key":"R21-8-20210211","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"R22-8-20210211","first-page":"2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).","volume":"285","year":"2008","journal-title":"JAMA"},{"key":"R23-8-20210211","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1097\/01.ju.0000121441.76094.6f","article-title":"The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation.","volume":"171","author":"Goel","year":"2004","journal-title":"J Urol"},{"key":"R24-8-20210211","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/ndt\/gfm621","article-title":"A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.","volume":"23","author":"Montagnino","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R25-8-20210211","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0012.2005.00326.x","article-title":"Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data.","volume":"19","author":"Lorber","year":"2005","journal-title":"Clin Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181bb43ec","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:04:12Z","timestamp":1786039452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200911270-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,27]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181bb43ec","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,27]]}}}